Radiopharm Theranostics Limited ADR (RADX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Fiscal Year End Date: 06/30
(Values in U.S. thousands)
| 06-2025 | 06-2024 | |
| Assets | ||
| Current Assets | ||
| Cash & Cash Equivalents | 18,856 | 12,182 |
| Receivables | 6,735 | 648 |
| Other current assets | 218 | 2,155 |
| TOTAL | $25,809 | $14,984 |
| Non-Current Assets | ||
| PPE Net | 35 | 40 |
| Investments And Advances | 0 | 26 |
| Intangibles | 30,162 | 32,191 |
| TOTAL | $30,196 | $32,258 |
| Total Assets | $56,006 | $47,241 |
| Liabilities | ||
| Current Liabilities | ||
| Accounts payable and accrued liabilities | 6,049 | 7,120 |
| Other current liabilities | 2,507 | 4,406 |
| TOTAL | $9,671 | $11,526 |
| Non-Current Liabilities | ||
| Deferred Revenues | 1,114 | N/A |
| Other Non-Current Liabilities | 18,571 | 17,777 |
| TOTAL | $18,571 | $17,777 |
| Total Liabilities | $28,242 | $29,303 |
| Shareholders' Equity | ||
| Common Shares | 114,339 | 66,027 |
| Retained earnings | -94,377 | -73,016 |
| Other shareholders' equity | 7,801 | 24,927 |
| TOTAL | $27,764 | $17,938 |
| Total Liabilities And Equity | $56,006 | $47,242 |